BRENTFORD, ENGLAND, UNITED KINGDOM, October 14, 2025 / EINPresswire.com / -- The global CRISPR gene-editing market is expected to witness significant growth, projected to rise from a valuation of US$ ...
Explore opportunities in protein engineering to innovate therapeutic and industrial applications. Enhance your skills in molecular biology and protein chemistry to develop cutting-edge protein-based ...
Announcing a new article publication for Zoonoses journal. As global warming increases, mosquito activity areas are expanding, alongside changes in the natural environment and the misuse of ...
Hosted on MSN
CRISPR-Cas9 gene editing trial results support further development as treatment for hereditary angioedema
A single treatment with a CRISPR-Cas9 based gene editing therapy is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...
The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 gene-editing tool to spiders. Following the genetic modification, the spiders ...
Intellia Therapeutics completed enrollment in the phase 3 HAELO study for lonvo-z, targeting Hereditary Angioedema attacks prevention. NTLA expects topline HAELO study data in 1H 2026, with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback